AzurRx BioPharma, Inc. (AZRX) analyst actions
Rating and price-target actions on AZRX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AZRX overview →
No AZRX analyst action events in the measured window.
Nothing matched in the current window — the AZRX overview has every event we measure for this name.
Get an email when AZRX moves on news →Keep exploring
More AZRX: earnings → · SEC filings → · AZRX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Immutep Limited - American Depositary Shares (IMMP) | 494 | -0.42% | 42% |
| FOAMIX PHARMACEUTICALS LTD (FOMX) | 493 | -0.29% | 41% |
| CONATUS PHARMACEUTICALS INC (CNAT) | 492 | -0.22% | 44% |
| Midatech Pharma PLC - American Depositary Shares (MTP) | 492 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.